Page 8 - Amyris Femme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amyris femme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amyris Femme Today - Breaking & Trending Today

Amyris (NASDAQ:AMRS) Rating Lowered to Sell at Zacks Investment Research

Amyris (NASDAQ:AMRS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports. According to Zacks, “Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms […] ....

United States , Amyris Inc , Hudock Inc , Zacks Investment Research , Prospera Financial Services Inc , Associates Corp , Capital Performance Advisors , Gordian Capital Singapore Pte Ltd , Get Rating , Capital Singapore Pte Ltd , Financial Services Inc , North America , Nasdaq Amrs , Basic Material ,

Amyris, Inc. (NASDAQ:AMRS) Given Consensus Rating of "Hold" by Analysts

Amyris, Inc. (NASDAQ:AMRS – Get Rating) has earned an average recommendation of “Hold” from the seven analysts that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokerages that have […] ....

United States , Dekabank Deutsche Girozentrale , Amyris Inc , Zacks Investment Research , Edmond De Rothschild Holding , Millennium Management , Get Rating , Investment Research , Bank Deutsche Girozentrale , Montreal Can , Michigan Retirement System , North America , Nasdaq Amrs , Basic Material ,

Amyris, Inc. (NASDAQ:AMRS) Expected to Post Quarterly Sales of $65.45 Million

Analysts expect that Amyris, Inc. (NASDAQ:AMRS – Get Rating) will post sales of $65.45 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Amyris’ earnings, with estimates ranging from $54.90 million to $85.00 million. Amyris reported sales of $176.86 million in the same quarter last year, which would […] ....

United States , Amyris Inc , Geode Capital Management , Alphacrest Capital Management , Zacks Investment Research , Swiss National Bank , Deutsche Bank , Capital Performance Advisors , Get Rating , Zacks Investment , Investment Research , Capital Management , National Bank , Performance Advisors , North America , Nasdaq Amrs , Basic Material ,

AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT

/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through. ....

Barra Bonita , John Melo , Prnewswire Amyris Inc , Amyris Inc , Clean Health Beauty , Chief Executive , Mclean Health ,

$65.45 Million in Sales Expected for Amyris, Inc. (NASDAQ:AMRS) This Quarter

Wall Street analysts forecast that Amyris, Inc. (NASDAQ:AMRS – Get Rating) will post $65.45 million in sales for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Amyris’ earnings. The lowest sales estimate is $54.90 million and the highest is $85.00 million. Amyris posted sales of $176.86 million during the same […] ....

United States , Dekabank Deutsche Girozentrale , Amyris Inc , Zacks Investment Research , Edmond De Rothschild Holding , Millennium Management , Wall Street , Get Rating , Investment Research , Bank Deutsche Girozentrale , Montreal Can , Michigan Retirement System , North America , Nasdaq Amrs , Basic Material ,